Polar Asset Management Partners’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Polar Asset Management Partners’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-324,020	Closed	-$42.7M	–	782
2025 Q1	$42.7M	Buy	+324,020	New	+$40.4M	0.99%	16
2023 Q1	–	Sell	-71,600	Closed	-$3.79M	–	1187
2022 Q4	$3.79M	Hold	71,600	–	–	0.05%	498
2022 Q3	$3.33M	Buy	+71,600	New	+$3.74M	0.04%	601

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Polar Asset Management Partners's ITCI Position: Q2 2025 in Review

Polar Asset Management Partners sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 324,020 shares — an estimated $42.7M sold.

Polar Asset Management Partners first reported a position in ITCI in Q3 2022 and held it in 3 quarters. The position peaked at $42.7M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Polar Asset Management Partners reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Polar Asset Management Partners sold 324,020 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $42.7M.
Polar Asset Management Partners first reported a position in Intra-Cellular Therapies Inc. in Q3 2022 and held it in 3 quarters.
Polar Asset Management Partners's Intra-Cellular Therapies Inc. position peaked at $42.7M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Polar Asset Management Partners's 13F filing for Q2 2025, filed 14 Aug 2025.